摘要
目的探讨转移性乳腺癌免疫治疗研究进展。方法通过检索国内外文献,对转移性乳腺癌免疫治疗相关文献加以综述。结果近年来,免疫治疗在转移性乳腺癌患者中得到初步尝试,在转移性乳腺癌的治疗展现了其独特的价值,为提高治疗效果及延长患者的生存时间提供了新途径。结论免疫疗法在三阴性转移性乳腺癌中最为有效。需要发展免疫肿瘤学组合,以提高乳腺癌免疫治疗的临床效益。
Objective To summarize the research progress of immunotherapy for metastatic breast cancer.Method Literatures about immunotherapy for metastatic breast cancer were reviewed by searching the literatures in domestic and foreign database.Results In recent years,immunotherapy had been initially attempted in patients with metastatic breast cancer and showed its unique value.It provided a new way to improve the therapeutic effect and prolong the survival time of patients with metastatic breast cancer.Conclusions Immunotherapy is the most effective in triplenegative metastatic breast cancers.The immuno-oncology needs to be developed to improve the clinical benefits of immunotherapy for breast cancer.
作者
俞鑫
孙圣荣
王卫星
YU Xin;SUN Shengrong;WANG Weixing(Department of Breast and Thyroid Surgery,Renmin Hospital of Wuhan University,Wuhan 430060,P.R.China;Department of Hepatobiliary Surgery,Renmin Hospital of Wuhan University,Wuhan 430060,P.R.China)
出处
《中国普外基础与临床杂志》
CAS
2022年第4期539-544,共6页
Chinese Journal of Bases and Clinics In General Surgery
关键词
转移性乳腺癌
免疫治疗
三阴性乳腺癌
免疫检查点抑制剂
metastatic breast cancer
immunotherapy
triple-negative breast cancer
immune checkpoint inhibitor